Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Global Prevalence of Cancer
4.2.2 Advancements in Cancer Therapy Technologies
4.2.3 Advantages of IORT over External beam radiotherapy
4.3 Market Restraints
4.3.1 Complexity of Technology and Shortage of Trained Personnel
4.3.2 Preference for Conventional Radiotherapy Over Intraoperative Radiation Therapy
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Method
5.1.1 Electron IORT
5.1.2 Intraoperative Brachytherapy
5.2 By Product & Service
5.2.1 Products
5.2.1.1 Systems/Accelerators
5.2.1.2 Applicators & Afterloaders
5.2.1.3 Treatment Planning Systems
5.2.1.4 Accessories
5.2.2 Services
5.3 By Application
5.3.1 Breast Cancer
5.3.2 Brain Tumor
5.3.3 Gastrointestinal Cancer
5.3.4 Head & Neck Cancer
5.3.5 Other Cancers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ariane Medical Systems, Ltd.
6.1.2 Eckert & Ziegler
6.1.3 Elekta AB
6.1.4 GMV Innovating Solutions
6.1.5 ICAD, Inc.
6.1.6 Intraop Medical Corporation
6.1.7 Sensus Healthcare, Inc.
6.1.8 Sordina IORT Technologies
6.1.9 Varian Medical Systems, Inc.
6.1.10 Zeiss Group


7 MARKET OPPORTUNITIES AND FUTURE TRENDS